Exome Asset Management »

Boston Scientific Corporation shares owned by Exome Asset Management

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.6M 41k 89.32

More positions owned by Exome Asset Management

Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
Guardant Health (GH)
Eli Lilly & Co. (LLY)
I Mab Sponsored Ads (IMAB)
Praxis Precision Medicines I Com New (PRAX)
Vera Therapeutics Cl A (VERA)
Astrazeneca Sponsored Adr (AZN)
Disc Medicine (IRON)
89bio (ETNB)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Tenet Healthcare Corp Com New (THC)

View all positions for Exome Asset Management

Top funds holding Boston Scientific Corporation

BlackRock
Vanguard Group
FMR
State Street Corporation
PRIMECAP Management Company
Geode Capital Management
Jpmorgan Chase & Co
Capital World Investors
Bollard
Invesco
Goldman Sachs Group
Wellington Management Company
Northern Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Amundi

View all funds holding Boston Scientific Corporation